Research sponsors are continuing to outsource management of their clinical trials in part or in full to clinical research organizations for a variety of reasons.
Sponsors may be looking for medical device or task expertise, resources beyond internal capabilities, or cost efficiency. And since sponsors will likely spend millions of dollars for a pivotal phase, significant risk medical device trial, they will want to select a CRO that understands their important role as a partner in compliance to protect their investment.
What makes a CRO a partner in compliance? Download our new whitepaper to review what a compliance-minded CRO should deliver.